Literature DB >> 26310158

Scleral Mechanisms Underlying Ocular Growth and Myopia.

Ravi Metlapally1, Christine F Wildsoet2.   

Abstract

In the regulation of ocular growth, scleral events critically determine eye size and thus the refractive status of the eye. Increased scleral matrix remodeling can lead to exaggerated eye growth causing myopia and additionally increased risk of ocular pathological complications. Thus, therapies targeting these changes in sclera hold potential to limit such complications since sclera represents a relatively safe and accessible drug target. Understanding the scleral molecular mechanisms underlying ocular growth is essential to identifying plausible therapeutic targets in the sclera. This section provides a brief update on molecular studies that pertain to the sclera in the context of ocular growth regulation and myopia.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eye growth; Myopia; Sclera

Mesh:

Year:  2015        PMID: 26310158      PMCID: PMC4687967          DOI: 10.1016/bs.pmbts.2015.05.005

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  38 in total

1.  Scleral changes in pathological myopia.

Authors:  B J CURTIN; C C TENG
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1958 Nov-Dec

Review 2.  Homeostasis of eye growth and the question of myopia.

Authors:  Josh Wallman; Jonathan Winawer
Journal:  Neuron       Date:  2004-08-19       Impact factor: 17.173

3.  Whole genome expression profiling of normal human fetal and adult ocular tissues.

Authors:  Terri L Young; Felicia Hawthorne; Sheng Feng; Xiaoyan Luo; Elizabeth St Germain; Minyue Wang; Ravikanth Metlapally
Journal:  Exp Eye Res       Date:  2013-09-07       Impact factor: 3.467

4.  Histology of the parapapillary region in high myopia.

Authors:  Jost B Jonas; Shefali B Jonas; Rahul A Jonas; Leonard Holbach; Songhomitra Panda-Jonas
Journal:  Am J Ophthalmol       Date:  2011-08-06       Impact factor: 5.258

5.  Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).

Authors:  Audrey Chia; Wei-Han Chua; Yin-Bun Cheung; Wan-Ling Wong; Anushia Lingham; Allan Fong; Donald Tan
Journal:  Ophthalmology       Date:  2011-10-02       Impact factor: 12.079

6.  Regulation of the mechanical properties of tree shrew sclera by the visual environment.

Authors:  J T Siegwart; T T Norton
Journal:  Vision Res       Date:  1999-01       Impact factor: 1.886

7.  Normal and staphylomatous sclera of high myopia. An electron microscopic study.

Authors:  B J Curtin; T Iwamoto; D P Renaldo
Journal:  Arch Ophthalmol       Date:  1979-05

8.  The efficacy and safety of posterior pole buckles in the control of progressive high myopia.

Authors:  B Ward; E P Tarutta; M J Mayer
Journal:  Eye (Lond)       Date:  2009-12       Impact factor: 3.775

9.  Reduced extracellular matrix in mammalian sclera with induced myopia.

Authors:  T T Norton; J A Rada
Journal:  Vision Res       Date:  1995-05       Impact factor: 1.886

10.  Isoform-specific changes in scleral transforming growth factor-beta expression and the regulation of collagen synthesis during myopia progression.

Authors:  Andrew I Jobling; Martin Nguyen; Alex Gentle; Neville A McBrien
Journal:  J Biol Chem       Date:  2004-01-28       Impact factor: 5.157

View more
  22 in total

Review 1.  The role of microRNAs in myopia.

Authors:  Bo Jiang; Yanan Huo; Yangshun Gu; Jianyong Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-11       Impact factor: 3.117

Review 2.  Characterization of the geometric properties of the sclero-conjunctival structure: a review.

Authors:  Laurent Bataille; David P Piñero
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

Review 3.  A Review of Intraocular Pressure (IOP) and Axial Myopia.

Authors:  Dongyan Zhang; Liyin Wang; Le Jin; Yingying Wen; Xuhong Zhang; Liyue Zhang; Hong Zhu; Ziyu Wang; Xin Yu; Chen Xie; Jianping Tong; Ye Shen
Journal:  J Ophthalmol       Date:  2022-07-09       Impact factor: 1.974

4.  Morphological differences between two types of Bruch's membrane defects in pathologic myopia.

Authors:  Jiamin Xie; Qiuying Chen; Guangyi Hu; Yao Yin; Haidong Zou; Jiangnan He; Jianfeng Zhu; Ying Fan; Xun Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-26       Impact factor: 3.117

5.  α-adrenergic agonist brimonidine control of experimentally induced myopia in guinea pigs: A pilot study.

Authors:  Yan Liu; Yuexin Wang; Huibin Lv; Xiaodan Jiang; Mingzhou Zhang; Xuemin Li
Journal:  Mol Vis       Date:  2017-11-15       Impact factor: 2.367

6.  Spatial Patterns and Age-Related Changes of the Collagen Crimp in the Human Cornea and Sclera.

Authors:  Alexandra Gogola; Ning-Jiun Jan; Bryn Brazile; Po Lam; Kira L Lathrop; Kevin C Chan; Ian A Sigal
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.799

Review 7.  The Combined Effect of Low-dose Atropine with Orthokeratology in Pediatric Myopia Control: Review of the Current Treatment Status for Myopia.

Authors:  José-María Sánchez-González; Concepción De-Hita-Cantalejo; María-José Baustita-Llamas; María Carmen Sánchez-González; Raúl Capote-Puente
Journal:  J Clin Med       Date:  2020-07-24       Impact factor: 4.241

8.  Endoplasmic Reticulum Stress Regulates Scleral Remodeling in a Guinea Pig Model of Form-Deprivation Myopia.

Authors:  Chengcheng Zhu; Qingzhong Chen; Ying Yuan; Min Li; Bilian Ke
Journal:  J Ophthalmol       Date:  2020-06-10       Impact factor: 1.909

Review 9.  Biological Mechanisms of Atropine Control of Myopia.

Authors:  Aradhana Upadhyay; Roger W Beuerman
Journal:  Eye Contact Lens       Date:  2020-05       Impact factor: 3.152

10.  Atropine Differentially Modulates ECM Production by Ocular Fibroblasts, and Its Ocular Surface Toxicity Is Blunted by Colostrum.

Authors:  Martina Cristaldi; Melania Olivieri; Salvatore Pezzino; Giorgia Spampinato; Gabriella Lupo; Carmelina Daniela Anfuso; Dario Rusciano
Journal:  Biomedicines       Date:  2020-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.